Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dogmas, challenges, and promises in phase III allergen immunotherapy studies.
De Kam PJ, Kramer MF, Shamji MH, Oluwayi K, Heath MD, Jensen-Jarolim E, Berger MH, Berger UE, Graessel A, Sellwood F, Zielen S, Vogelberg C, Zieglmayer P, Mösges R, Klimek L, DuBuske LM, Shreffler WG, Bernstein JA, Kündig TM, Skinner MA. De Kam PJ, et al. Among authors: berger ue. World Allergy Organ J. 2021 Sep 28;14(9):100578. doi: 10.1016/j.waojou.2021.100578. eCollection 2021 Sep. World Allergy Organ J. 2021. PMID: 34659627 Free PMC article. Review.
Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paper.
Pfaar O, Bastl K, Berger U, Buters J, Calderon MA, Clot B, Darsow U, Demoly P, Durham SR, Galán C, Gehrig R, Gerth van Wijk R, Jacobsen L, Klimek L, Sofiev M, Thibaudon M, Bergmann KC. Pfaar O, et al. Allergy. 2017 May;72(5):713-722. doi: 10.1111/all.13092. Epub 2017 Jan 27. Allergy. 2017. PMID: 27874202 Review.
Differences in Reporting the Ragweed Pollen Season Using Google Trends across 15 Countries.
Bousquet J, Agache I, Berger U, Bergmann KC, Besancenot JP, Bousquet PJ, Casale T, d'Amato G, Kaidashev I, Khaitov M, Mösges R, Nekam K, Onorato GL, Plavec D, Sheikh A, Thibaudon M, Vautard R, Zidarn M. Bousquet J, et al. Int Arch Allergy Immunol. 2018;176(3-4):181-188. doi: 10.1159/000488391. Epub 2018 May 9. Int Arch Allergy Immunol. 2018. PMID: 29742519 Free article. Review.
Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms.
Campana R, Marth K, Zieglmayer P, Weber M, Lupinek C, Zhernov Y, Elisyutina O, Khaitov M, Rigler E, Westritschnig K, Berger U, Wolkersdorfer M, Horak F Jr, Horak F, Valenta R. Campana R, et al. J Allergy Clin Immunol. 2019 Mar;143(3):1258-1261. doi: 10.1016/j.jaci.2018.11.011. Epub 2018 Nov 22. J Allergy Clin Immunol. 2019. PMID: 30471304 Free PMC article. Clinical Trial. No abstract available.
Shortened up-dosing with sublingual immunotherapy drops containing tree allergens is well tolerated and elicits dose-dependent clinical effects during the first pollen season.
Mösges R, Breitrück NY, Allekotte S, Shah-Hosseini K, Dao VA, Zieglmayer P, Birkholz K, Hess M, Bastl M, Bastl K, Berger U, Kramer MF, Guethoff S. Mösges R, et al. World Allergy Organ J. 2019 Mar 8;12(2):100012. doi: 10.1016/j.waojou.2019.100012. eCollection 2019. World Allergy Organ J. 2019. PMID: 30937138 Free PMC article.
71 results